Antiviral Research

Article	Citations
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro	1399
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade	1343
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro	685
Coronavirus membrane fusion mechanism offers a potential target for antiviral development	606
Of chloroquine and COVID-19	417
Type 1 interferons as a potential treatment against COVID-19	392
Antiviral activities of type I interferons to SARS-CoV-2 infection	331
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern	293
A potential role for integrins in host cell entry by SARS-CoV-2	253
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites	251
The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer	235
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions	227
Hepatitis B virus biology and life cycle	146
Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors	110
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2	110
Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2	103
A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19	95
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters	90
Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential	87
Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses	86
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017–2018	86
A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase	68
Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance	66
Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B	60
Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes	59

Put a cork in it: Plugging the M2 viral ion channel to sink influenza	54
Inhibition of herpes simplex virus by myricetin through targeting viral gD protein and cellular EGFR/PI3K/Akt pathway	49
A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents	46
An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral	44
Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro	43
Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation	43
Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro	43
Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E	42
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020	41
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection	39
Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis	39
Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro	39
Current understanding of human herpesvirus 6 (HHV-6) chromosomal integration	38
Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses	38
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice	36
Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection	36
Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses	36
Mechanisms of HBV immune evasion	36
Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies	36
HBV replication inhibitors	35
Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (−) and the eIF4A-inhibitor Silvestrol	35
Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development	33
Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry	33
Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir	32
Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system	32
Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo	32
Burden of influenza B virus infection and considerations for clinical management	32
An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection	32
Current knowledge on Hepatitis Delta Virus replication	30
Antiviral activity of Apigenin against buffalopox: Novel mechanistic insights and drug-resistance considerations	30
Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection	30
Adoptive T-cell therapy for HBV-associated HCC and HBV infection	30
Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry	30
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2	30
Cinnamic acid inhibits Zika virus by inhibiting RdRp activity	29
Generation and characterization of Japanese encephalitis virus expressing GFP reporter gene for high throughput drug screening	28
HBV evolution and genetic variability: Impact on prevention, treatment and development of antivirals	28
Artemisinin inhibits the replication of flaviviruses by promoting the type I interferon production	27
Betulinic acid exhibits antiviral effects against dengue virus infection	27
A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2	27
A synthetic STING agonist inhibits the replication of human parainfluenza virus 3 and rhinovirus 16 through distinct mechanisms	26
In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs’ cleavage by CRISPR/Cas13a system	25
Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors	25
Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues	25
The rocaglate CR-31-B (−) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo	25
The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro	24
Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group	24
Inhibition of herpes simplex virus 1 by cepharanthine via promoting cellular autophagy through up-regulation of STING/TBK1/P62 pathway	24
ML-SA1, a selective TRPML agonist, inhibits DENV2 and ZIKV by promoting lysosomal acidification and protease activity	23
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro	23

Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation	22
Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro	22
The direct and indirect consequences of cytomegalovirus infection and potential benefits of vaccination	22
Diketo acids inhibit the cap-snatching endonuclease of several Bunyavirales	22
Iminosugars: A host-targeted approach to combat Flaviviridae infections	22
Allosteric inhibitors of the main protease of SARS-CoV-2	22
Influenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment	22
Methyl-β-cyclodextrin inhibits EV-D68 virus entry by perturbing the accumulation of virus particles and ICAM-5 in lipid rafts	22
Effectiveness of pegylated interferon monotherapy in the treatment of chronic hepatitis D virus infection: A meta-analysis	22
Antiviral drugs targeting endosomal membrane proteins inhibit distant animal and human pathogenic viruses	22
Amide-containing α-hydroxytropolones as inhibitors of hepatitis B virus replication	21
Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques	21
Antiviral efficacy against influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model	21
Reasons to consider early treatment in chronic hepatitis B patients	20
Synthesis and antiviral effect of novel fluoxetine analogues as enterovirus 2C inhibitors	20
Clinical outcome and the role of antivirals in congenital cytomegalovirus infection	20
Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening	20
Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication	20
Targeting host DEAD-box RNA helicase DDX3X for treating viral infections	20
Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral binding	19
COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference	19
Identification of potassium and calcium channel inhibitors as modulators of polyomavirus endosomal trafficking	19
Drug screening identifies gemcitabine inhibiting rotavirus through alteration of pyrimidine nucleotide synthesis pathway	19
Perspectives on stopping nucleos(t)ide analogues therapy in patients with chronic hepatitis B	19
Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target	19
Prevention and treatment of neonatal herpes simplex virus infection	18
New methylene blue derivatives suggest novel anti-orthopoxviral strategies	18
Antiviral activities of four marine sulfated glycans against adenovirus and human cytomegalovirus	18
Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease	18
Hepatoprotective, antioxidant, anti-inflammatory, and antiviral activities of silymarin against mayaro virus infection	18
Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augm	18
Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro	17
14-Deoxy-11,12-didehydroandrographolide inhibits apoptosis in influenza A(H5N1) virus-infected human lung epithelial cells via the caspase-9-dependent intrinsic apoptotic pathway which contributes to	17
Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase	17
A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc)DNA formation and maintenance	17
E3 ubiquitin ligase TRIM21 restricts hepatitis B virus replication by targeting HBx for proteasomal degradation	17
Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies	16
Characterization of contemporary influenza B recombinant viruses harboring mutations of reduced susceptibility to baloxavir marboxil, in vitro and in mice	16
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2	16
Failure to bictegravir and development of resistance mutations in an antiretroviral-experienced patient	16
MDA5 against enteric viruses through induction of interferon-like response partially via the JAK-STAT cascade	16
Influenza antivirals and their role in pandemic preparedness	16
Glibenclamide inhibits BK polyomavirus infection in kidney cells through CFTR blockade	15
A small molecule inhibitor of MyD88 exhibits broad spectrum antiviral activity by up regulation of type I interferon	15
The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection	15
Sofosbuvir shows a protective effect against vertical transmission of Zika virus and the associated congenital syndrome in rhesus monkeys	15
Identification and structural characterization of small molecule fragments targeting Zika virus NS2B-NS3 protease	15
Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro	15
5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis	15
Prophylaxis of ferrets with nitazoxanide and oseltamivir combinations is more effective at reducing the impact of influenza a virus infection compared to oseltamivir monotherapy	15
Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein	15
S-adenosylmethionine-dependent methyltransferase inhibitor DZNep blocks transcription and translation of SARS-CoV-2 genome with a low tendency to select for drug-resistant viral variants	15
Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir	14
The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium	14
Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening	14
Generation of a reporter yellow fever virus for high throughput antiviral assays	14
A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection	14
Potent in vitro activity of β-D-4ʹ-chloromethyl-2ʹ-deoxy-2ʹ-fluorocytidine against Nipah virus	14
Substitution-inert polynuclear platinum compounds inhibit human cytomegalovirus attachment and entry	14
Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis	14
Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90	14
A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge	14
A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera	14
A highly potent trimeric derivative of artesunate shows promising treatment profiles in experimental models for congenital HCMV infection in vitro and ex vivo	14
Next-generation sequencing for cytomegalovirus antiviral resistance genotyping in a clinical virology laboratory	14
Cetylpyridinium chloride blocks herpes simplex virus replication in gingival fibroblasts	14
ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern	13
A dengue type 2 reporter virus assay amenable to high-throughput screening	13
Anti-flavivirus activity of polyoxometalate	13
In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2	13
Duration of fever and symptoms in children after treatment with baloxavir marboxil and oseltamivir during the 2018–2019 season and detection of variant influenza a viruses with polymerase acidic subun	13
NK-lysin peptides ameliorate viral encephalopathy and retinopathy disease signs and provide partial protection against nodavirus infection in European sea bass	13
Vaccine strain of O/ME-SA/Ind-2001e of foot-and-mouth disease virus provides high immunogenicity and broad antigenic coverage	13
Animal models for the study of human hepatitis B and D virus infection: New insights and progress	13
Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses	13
Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study	13
Detection of baloxavir resistant influenza A viruses using next generation sequencing and pyrosequencing methods	13
Enzymatically synthesized 2′-fluoro-modified Dicer-substrate siRNA swarms against herpes simplex virus demonstrate enhanced antiviral efficacy and low cytotoxicity	13
Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus	13
Broad neutralization activity against both PRRSV-1 and PRRSV-2 and enhancement of cell mediated immunity against PRRSV by a novel IgM monoclonal antibody	13

Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig	13
Suppression effect of plant-derived berberine on cyprinid herpesvirus 2 proliferation and its pharmacokinetics in Crucian carp (Carassius auratus gibelio)	13
Target verification of artesunate-related antiviral drugs: Assessing the role of mitochondrial and regulatory proteins by click chemistry and fluorescence labeling	13
Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1	13
Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor	12
Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2	12
Crystal structures of full length DENV4 NS2B-NS3 reveal the dynamic interaction between NS2B and NS3	12
Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients	12
The trimeric artesunate derivative TF27 exerts strong anti-cytomegaloviral efficacy: Focus on prophylactic efficacy and oral treatment of immunocompetent mice	12
Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs	12
Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses	12
DDX3 inhibitors show antiviral activity against positive-sense single-stranded RNA viruses but not against negative-sense single-stranded RNA viruses: The coxsackie B model	12
Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors	12
Comparative pathology study of Venezuelan, eastern, and western equine encephalitis viruses in non-human primates	12
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier	12
Topoisomerase III-β is required for efficient replication of positive-sense RNA viruses	12
Acyclovir, cidofovir, and amenamevir have additive antiviral effects on herpes simplex virus TYPE 1	12
Potential application of antiviral coumarin in aquaculture against IHNV infection by reducing viral adhesion to the epithelial cell surface	12
Hydroxypropyl-beta-cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication and virus-induced inflammatory cytokines	12
Functional neuraminidase inhibitor resistance motifs in avian influenza A(H5Nx) viruses	12
A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency	11
Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins	11
Immunobiology of Crimean-Congo hemorrhagic fever	11
Small molecule inhibitors possibly targeting the rearrangement of Zika virus envelope protein	11
Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariants	11
Reverse genetic systems of SARS-CoV-2 for antiviral research	11
LINCS dataset-based repositioning of rosiglitazone as a potential anti-human adenovirus drug	11
Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors	11
Infectious bronchitis virus: Identification of Gallus gallus APN high-affinity ligands with antiviral effects	11
Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses	11
Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method	11
The discovery and development of filociclovir for the prevention and treatment of human cytomegalovirus-related disease	10
Identification of hepatitis B virus core protein residues critical for capsid assembly, pgRNA encapsidation and resistance to capsid assembly modulators	10
The human α-defensin-derived peptide HD5(1–9) inhibits cellular attachment and entry of human cytomegalovirus	10
GS-441524 inhibits African swine fever virus infection in vitro	10
Reversible covalent inhibitors suppress enterovirus 71 infection by targeting the 3C protease	10
Comparative analysis of the molecular mechanism of resistance to vapendavir across a panel of picornavirus species	10
BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines	10
Ganciclovir and maribavir susceptibility phenotypes of cytomegalovirus UL97 ATP binding region mutations detected by expanded genotypic testing	10
BIKE regulates dengue virus infection and is a cellular target for broad-spectrum antivirals	10
SOX9 represses hepatitis B virus replication through binding to HBV EnhII/Cp and inhibiting the promoter activity	10
Licochalcone A inhibits enterovirus A71 replication in vitro and in vivo	10
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization	10
A novel cell culture model reveals the viral interference during hepatitis B and C virus coinfection	10
Conserved coronavirus proteins as targets of broad-spectrum antivirals	10
The NF-κB inhibitor, SC75741, is a novel antiviral against emerging tick-borne bandaviruses	10
Multivalent DNA vaccine protects against genital herpes by T-cell immune induction in vaginal mucosa	10
Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein	10
Hepatitis D virus: Improving virological knowledge to develop new treatments	9
Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virus	9
Viral replicon particles protect IFNAR-/- mice against lethal Crimean-Congo hemorrhagic fever virus challenge three days after vaccination	9
Development and characterization of recombinant tick-borne encephalitis virus expressing mCherry reporter protein: A new tool for high-throughput screening of antiviral compounds, and neutralizing ant	9
The involvement of annexin A1 in human placental response to maternal Zika virus infection	9
In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean–Congo hemorrhagic fever virus	9
Metabolic regulation of the HBV-specific T cell function	9
Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates	9
Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model	9
Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination w	9
Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production	9
Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides	9
Ergosterol peroxide inhibits HBV infection by inhibiting the binding of the pre-S1 domain of LHBsAg to NTCP	9
Regulation of Cas9 by viral proteins Tat and Rev for HIV-1 inactivation	9
Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses	9
Synergistic in-vitro antiviral effects of combination treatment using anidulafungin and T-1105 against Zika virus infection	9
A novel recombinant cccDNA-based mouse model with long term maintenance of rcccDNA and antigenemia	9
SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening	9
First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure	9
Inhibiting cytomegalovirus replication through targeting the host electron transport chain	9
High dose sofosbuvir and sofosbuvir-plus-ribavirin therapy inhibit Hepatitis E Virus (HEV) replication in a rabbit model for acute HEV infection	9
Use of the Guinea pig model of genital herpes to evaluate vaccines and antivirals: Review	9
Vector-borne viruses in Turkey: A systematic review and bibliography	9
Baloxavir-oseltamivir combination therapy inhibits the emergence of resistant substitutions in influenza A virus PA gene in a mouse model	9
Nafamostat mesylate as a broad-spectrum candidate for the treatment of flavivirus infections by targeting envelope proteins	9
Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model	8
An antibody engineering platform using amino acid networks: A case study in development of antiviral therapeutics	8
Broad spectrum compounds targeting early stages of rabies virus (RABV) infection	8
A fluorescence-based, gain-of-signal, live cell system to evaluate SARS-CoV-2 main protease inhibition	8
Interference of dengue replication by blocking the access of 3′ SL RNA to the viral RNA-dependent RNA polymerase	8
Remdesivir inhibits the polymerases of the novel filoviruses Lloviu and Bombali virus	8
7-Deaza-7-fluoro-2′-C-methyladenosine inhibits Zika virus infection and viral-induced neuroinflammation	8
New directions in the experimental therapy of tick-borne encephalitis	8
Targeting SARS-CoV-2 and host cell receptor interactions	8
TRIM56 impairs HBV infection and replication by inhibiting HBV core promoter activity	8
Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor	8
Ponesimod suppresses hepatitis B virus infection by inhibiting endosome maturation	8
The epigenetic landscapes of histone modifications on HSV-1 genome in human THP-1 cells	8
An efficient method for simultaneously screening for HIV, syphilis, and HCV based on one dried blood spot sample	8
Methodology-dependent performance of serum HBV RNA in predicting treatment outcomes in chronic hepatitis B patients	8
Apolipoprotein M, identified as a novel hepatitis C virus (HCV) particle associated protein, contributes to HCV assembly and interacts with E2 protein	8
Safety, pharmacokinetics and pharmacodynamics of SYN023 alone or in combination with a rabies vaccine: An open, parallel, single dose, phase 1 bridging study in healthy Chinese subjects	8
2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors	8
Relative frequency of cytomegalovirus UL56 gene mutations detected in genotypic letermovir resistance testing	8
Current status of silica-based nanoparticles as therapeutics and its potential as therapies against viruses	8
5-(Perylen-3-ylethynyl)uracil as an antiviral scaffold: Potent suppression of enveloped virus reproduction by 3-methyl derivatives in vitro	8
Pemetrexed inhibits Kaposi's sarcoma-associated herpesvirus replication through blocking dTMP synthesis	7